The state of Utah currently has 151 active clinical trials seeking participants for Cancer research studies. These trials are conducted in various cities, including Salt Lake City, Murray, Ogden and West Jordan.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Recruiting
The purpose of this study is to establish recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate cancer.
Gender:
Male
Ages:
18 years and above
Trial Updated:
04/28/2023
Locations: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Conditions: Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial
Recruiting
This protocol is a companion imaging study that will add FES-PET/CT imaging to the FORESEE trial at HCI. This study will establish the feasibility of using FES-PET/CT imaging to guide therapeutic decision making for functional precision oncology trials. The unique ability of FES-PET/CT to show absence of functional estrogen receptors throughout the entire body may improve confidence among research oncologists that an ER+ metastatic breast cancer patient is truly refractory to hormonal therapies... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/21/2023
Locations: Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah
Conditions: Estrogen Receptor Positive Breast Cancer
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Recruiting
This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/04/2023
Locations: University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
Conditions: Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC, ARID1A Gene Mutation, Small Cell Lung Cancer, SCLC
Sun-safe Habits Intervention and Education
Recruiting
The purpose of this study is to determine the efficacy of the Sun-safe Habits Intervention and Education (SHINE) intervention in improving sun protection use and decreasing intentional tanning among high school students. It's anticipated that 30 schools will be randomized into the trial, with approximately half assigned to SHINE and the other half assigned to standard education. After randomization and a baseline assessment, each school will receive two in-class intervention sessions delivered b... Read More
Gender:
All
Ages:
Between 11 years and 21 years
Trial Updated:
12/13/2022
Locations: Huntsman Cancer Institute, Salt Lake City, Utah
Conditions: Skin Cancer, Adolescents
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer
Recruiting
This is a phase 1/2a, first-in-human study to evaluate the safety and tolerability of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer
Gender:
Male
Ages:
18 years and above
Trial Updated:
11/18/2022
Locations: Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
Conditions: Metastatic Castration Resistant Prostate Cancer
Establish ProLung Test Measurement Collection Protocol for Future Studies.
Recruiting
The purpose of this Study is to identify and test different data collection methods to determine which approaches improve the ProLung Testing procedure. Once this Study is complete, the Sponsor plans to evaluate these improvements in future follow up Validation studies that will assess device accuracy using the new measurement collection methods.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/21/2022
Locations: Ogden Regional Medical Center, Ogden, Utah +1 locations
Conditions: Cancer , Healthy
ColoCare Study - Colorectal Cancer Cohort
Recruiting
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
05/22/2022
Locations: Huntsman Cancer Institute, Salt Lake City, Utah
Conditions: Colorectal Cancer